Main Industry
Biotechnology
Main Product/Service
Exosome Platform Technology
The content above was translated by Ai
Founded Year
2022
Unified Business No.
90623289
Status
Active
Number of Employees
0
Total Paid-in
Capital
125,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Through the technology transfer of a new exosome platform technology from the National Health Research Institutes (NHRI), the company has built an induced exosome technology platform, targeting the field of neurological diseases.
The content above was translated by Ai
